TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Capra Science Antibodies AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,470
|
3,856
|
4,200 |
| Financial expenses |
24
|
8
|
5 |
| Earnings before taxes |
134
|
454
|
453 |
| EBITDA |
388
|
636
|
611 |
| Total assets |
2,618
|
3,179
|
2,392 |
| Current assets |
1,308
|
1,844
|
1,402 |
| Current liabilities |
653
|
1,245
|
1,052 |
| Equity capital |
1,708
|
1,594
|
1,339 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
3
|
3
|
4 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
65.2%
|
50.1%
|
56.0% |
| Turnover per employee |
1,157
|
1,285
|
1,050 |
| Profit as a percentage of turnover |
3.9%
|
11.8%
|
10.8% |
| Return on assets (ROA) |
6.0%
|
14.5%
|
19.1% |
| Current ratio |
200.3%
|
148.1%
|
133.3% |
| Return on equity (ROE) |
7.8%
|
28.5%
|
33.8% |
| Change turnover |
-406
|
-3
|
310 |
| Change turnover % |
-10%
|
0%
|
8% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-25%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.